Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
4.840
-0.120 (-2.42%)
At close: Apr 28, 2026, 4:00 PM EDT
4.800
-0.040 (-0.83%)
After-hours: Apr 28, 2026, 7:57 PM EDT
Niagen Bioscience Employees
Niagen Bioscience had 117 employees as of December 31, 2025. The number of employees increased by 13 or 12.50% compared to the previous year.
Employees
117
Change (1Y)
13
Growth (1Y)
12.50%
Revenue / Employee
$1,106,179
Profits / Employee
$148,564
Market Cap
388.40M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Rocket Pharmaceuticals | 202 |
| Puma Biotechnology | 179 |
| Invivyd | 122 |
| Enanta Pharmaceuticals | 120 |
| Neumora Therapeutics | 96 |
| Century Therapeutics | 78 |
| Lineage Cell Therapeutics | 77 |
NAGE News
- 15 hours ago - Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™ - Business Wire
- 6 days ago - Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 - Business Wire
- 19 days ago - Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen® - Business Wire
- 4 weeks ago - Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas - Business Wire
- 5 weeks ago - Niagen Bioscience Increases Share Repurchase Program to $20 Million - Business Wire
- 5 weeks ago - Niagen Bioscience to Present at the 38th Annual ROTH Conference - Business Wire
- 6 weeks ago - Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies - Business Wire
- 7 weeks ago - Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen® - Business Wire